Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
The purpose of this study is to evaluate the effect of bimekizumab on gene expression biomarkers at Week 48 in a subset of study participants with moderate to severe plaque psoriasis (PSO) and moderate to severe plaque PSO with concomitant active psoriatic arthritis (PsA) who have provided skin biopsies for reverse transcription-polymerase chain reaction (RT-PCR).
Sponsor: UCB Biopharma SRL
Check if you qualify for this plaque psoriasis clinical trial in Rochester, NY
If you're searching for plaque psoriasis treatment options in Rochester, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.